evaluation 1
international 1
prognostic 2
score 2
ips 2
simpler 1
advanced 1
hodgkin 2
lymphoma 5
modern 1
era 1
phase 3
ii 3
intergroup 2
trial 3
alisertib 1
relapsed 2
refractory 2
peripheral 1
tcell 1
transformed 1
mycosis 1
fungoides 1
swog 1
randomized 1
iii 1
comparing 1
abvd 1
plus 1
radiotherapy 1
stanford 1
v 1
regimen 1
patients 3
stages 1
locally 1
extensive 1
bulky 1
mediastinal 1
subset 1
analysis 1
north 1
american 1
e 1
outcomes 1
burkitt 1
older 1
age 1
treated 1
intensive 1
chemotherapeutic 1
regimens 1
multicenter 1
study 1
bortezomib 1
mantle 1
cell 1
